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Abstract
Medicare conducted a payment demonstration to evaluate the effectiveness of two
intensive lifestyle modification programs in patients with symptomatic coronary
artery disease: the Dr. Dean Ornish Program for Reversing Heart Disease (Ornish)
and Cardiac Wellness Program of the Benson-Henry Mind Body Institute. This
report describes the changes in cardiac risk factors achieved by each program
during the active intervention year and subsequent year of follow-up. The
demonstration enrolled 580 participants who had had an acute myocardial
infarction, had undergone coronary artery bypass graft surgery or percutaneous
coronary intervention within 12 months, or had documented stable angina pectoris.
Of these, 98% completed the intense 3-month intervention, 71% the 12-month
intervention, and 56% an additional follow-up year. Most cardiac risk factors
improved significantly during the intense intervention period in both programs.
Favorable changes in cardiac risk factors and functional cardiac capacity were
maintained or improved further at 12 and 24 months in participants with active
follow-up. Multivariable regressions found that risk-factor improvements were
positively associated with abnormal baseline values, Ornish program participation
for body mass index and systolic blood pressure, and with coronary artery bypass
graft surgery. Expressed levels of motivation to lose weight and maintain weight
loss were significant independent predictors of sustained weight loss (p50.006).
Both lifestyle modification programs achieved well-sustained reductions in cardiac
risk factors.
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Introduction
Cardiovascular disease is a major cause of mortality and disability despite
widespread efforts to control cardiac risk factors through diet, exercise, and
medications. Though death rates due to cardiovascular disease (CVD) declined
30.6% between 1998 and 2008, in 2008, 82.6 million U.S. citizens had CVD and
811,900 died from it, its associated direct and indirect costs totaled $297.7 billion.
In 2009, 416,000 underwent coronary artery bypass graft (CABG) surgery and
596,000 received percutaneous coronary interventions (PCIs) [1].
Cardiac risk factors contribute importantly to the development of coronary
heart disease (CHD). Obesity, diabetes, serum cholesterol levels, hypertension,
smoking, inadequate exercise, and stress each provides an important target for
efforts to reduce associated morbidity and mortality. Cardiac rehabilitation (CR)
programs have been the most thoroughly studied. These programs typically begin
in the hospital setting following a cardiac event and include monitored aerobic
exercise, dietary advice, and other services to achieve lipid control, weight loss,
and stress modification. [2, 3, 4, 5, 6, 7] Meta-analyses of controlled trials of CR
have demonstrated 15% to 28% reductions in all-cause mortality. [8, 9, 10, 11, 12]
Generalizability of these findings is limited, however, because most studies
included relatively few older persons, women, members of racial/ethnic
minorities, or high-risk patients including those with congestive heart failure.
Programs aimed at secondary cardiac prevention have also been conducted in
health care centers outside of hospitals or at home. A meta-analysis that included
63 randomized trials of this type and over 21,000 patients with CHD showed a
15% reduction in all-cause mortality and a 17% reduction of acute myocardial
infarctions (AMIs). [8, 12] Effects were similar whether or not the risk factor
reduction program included structured exercise. More than half of the studies
reported favorable effects on cardiac risk factors including cholesterol profiles and
functional status, though effect sizes were generally small and were statistically
significant in only half of studies. Ornish reported that intensive lifestyle changes
may reverse coronary artery arteriosclerosis [13, 14].
Methods
Medicare conducted a payment demonstration from 2000 to 2008 to examine the
effects of intense lifestyle modification programs in patients with symptomatic
coronary artery disease or recent cardiac events on cardiac risk factors and the
progression of CVD, health outcomes, and the cost-effectiveness of care. The
demonstration involved two multisite programs: The Dr. Dean Ornish Program
for Reversing Heart Disease (Ornish) and the Cardiac Wellness Program of the
Benson-Henry Mind/Body Medical Institute (MBMI). Enrollment lasted from
2000 until 2006 and aimed to achieve two years of follow-up in each participant.
This report focuses on changes in cardiac risk factors that were achieved over the
two-year follow-up period.
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Demonstration Design
The demonstration involved 12 Ornish sites and 5 MBMI sites and included both
fee-for-service and managed care Medicare beneficiaries. Enrollment began in
2000 for the Ornish program and in 2002 for the MBMI program and ended for
both programs in February 2006. Two years of follow-up for all enrollees was
completed in February 2008. Objectives were to reduce the levels of cardiac risk
factors and the risk of future cardiovascular events in participants. Each program
included an intense three-month intervention period followed by nine months of
less frequent sessions and greater emphasis on home maintenance of healthy
lifestyle behaviors. Follow-up continued for an additional 12 months.
Evaluation Design
This report focuses on enrollment into the two programs and their effects on
cardiac risk factors, exercise tolerance, and the occurrence of cardiovascular events
during two years of follow-up. During the demonstration, Medicare reimbursed
each 12-month program’s negotiated fees that were linked to active participation
during each 3-month period.
Eligibility Criteria
Participants were 65 years of age or older, had had an AMI, CABG, or PCI within
the previous 12 months, or had stable angina pectoris with cardiac ischemia
documented by coronary angiography or a stress echocardiogram. Patients with
high-risk cardiac conditions were excluded, including those with a 50 percent or
greater narrowing of the left main coronary artery, three-vessel disease, a left
ventricular ejection fraction of less than 30%, two-vessel disease with occlusions of
70% or more and an ejection fraction of less than 30%, unstable angina, high-risk
exercise or nuclear stress test results, or American Heart Association Level IV
congestive heart failure. Individuals with impaired cognitive function were also
excluded, as were those whose travel time from home to the program site was
more than 90 minutes under usual traffic conditions.
Lifestyle Modification Program Interventions
Each program included exercise, nutrition counseling, stress management, and
small group support. The Ornish program had a 12-week intense phase that
included three 4-hour sessions in week 1, two in weeks 2 through 11, and three in
week 12. Nutrition counseling targeted a vegetarian diet with 10% or fewer
calories from fat. During the remainder of the first year, participants received
either 12 or 24 weeks of two-hour weekly sessions or 40 weeks of four-hour weekly
sessions based on their medical risk stratification and adherence to lifestyle change
guidelines. In the second year, they were offered assistance in obtaining self-
directed community follow-up and were periodically reevaluated.
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The MBMI program included similar components but was somewhat less
intense. Participants received one 3-hour session per week during the first 13
weeks. Emphasis was placed on adherence to the American Heart Association diet
(30% or fewer calories from fat), group support and behavior change, and one-
on-one health contracting and assessment sessions. During the rest of the first
year, they attended 3-hour sessions twice a month. At the end of the year, they
were given a program completion certificate, revised health contract, and
information about ‘‘graduate’’ groups and community resources. Outcomes were
monitored during the second year.
Data Sources
The clinical sites provided baseline data on candidates to the Delmarva
Foundation, Inc., a Professional Review Organization in Maryland that had
contracted with the Centers for Medicare and Medicaid Services (CMS) to
determine beneficiary eligibility for the demonstration and to monitor program
implementation. During programs, monthly data were provided to Delmarva to
document changes in cardiac risk factors and psychological outcomes, adherence
to program protocols, changes in medication regimens, and any adverse clinical
events that had occurred. Each participant was asked to complete a mailed survey
at the time of enrollment to provide information on sociodemographic
characteristics, prior health-related behaviors, and psychosocial characteristics.
Monitored cardiac risk factors included body weight, systolic and diastolic blood
pressure, total serum cholesterol, low density and high density cholesterol sub-
fractions, triglycerides, and hemoglobin A1c in patients with documented
diabetes.
Statistical Analysis
Descriptive statistics compare the baseline characteristics of participants in the
Ornish and MBMI programs and document risk factor changes at the end of the
intense intervention period (3 months), end of the active program (12 months),
and end of the follow-up period (24 months). Analysis of the program’s effects on
cardiac risk factors required that values be available at both baseline and the end
of each follow-up period. Targeted risk factors include low density lipoprotein
(LDL), body-mass index (BMI), systolic blood pressure (SBP), diastolic blood
pressure (DBP), and high density lipoproteins (HDL). Changes were calculated
from baseline both for participants with any data at a specified time point
(denoted by ANY) and those with full attendance (i.e., provided data at each time
point, denoted as FULL). The analysis with ANY data provides the largest and
most representative sample, while the FULL data analysis provides a consistent
cohort for comparison across time periods. Analysis of responses to a baseline
participant survey focused on race, level of education, smoking history, prior
efforts to lose weight and maintain weight loss, support from family and friends,
Effects of Lifestyle Modification Programs
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the ability to ‘‘take charge’’ of life’s challenges, and an overall rating of current
health status.
To adjust for differences among participants in comparing the programs,
multivariate regression analyses of changes in each cardiac risk factor adjusted for
the baseline level of the risk factor, type of program (MBMI or Ornish),
demonstration time period (measured in quarter years, in both linear and
quadratic terms), qualifying cardiac diagnosis, and the age, gender, race, and
educational level of the participant. The inclusion of the quadratic term for time
period allowed estimating how program impacts varied over the follow-up period.
IRB Approval
This evaluation was approved by Brandeis University’s Institutional Review Board
(IRB). All participants provided written informed consent.
Results
Participation in a Lifestyle Program
Enrollment and program completion rates are summarized in Table 1. A total of
580 Medicare beneficiaries participated in the demonstration, consisting of 440 in
the MBMI program and 140 in the Ornish program. Of these, 98% completed the
intense 3-month intervention, 71% the 12-month intervention, and 56% the
subsequent year of follow-up. Completion rates were similar in the two programs
during the active program year but were higher in the MBMI program at the end
of the follow-up year (58% versus 47%). Reasons for disenrollment from the
active program included medical causes in 63 participants, non-compliance in 64,
personal reasons in 44, and closures of clinical sites in 38. Less frequent reasons
included family issues, relocations, commuting problems, and conflicts with work.
Fourteen participants left the program to undergo surgery, including five who
received cardiac revascularization procedures. Eight patients died during the
demonstration period, including two from cardiac causes. Neither cardiac death
occurred during the active intervention period.
Baseline Characteristics of Participants
The mean age of participants was 71.5 years, 65% were male, and 85% were white.
(Table 2) They were highly educated and included 60% with at least some college
education and 38% with a 4-year college degree or more. The frequencies of
qualifying cardiac events differed between the Ornish and MBMI programs (chi
square p,0.05). More participants in the Ornish program had stable angina (19%
vs. 14%) or had received PCIs (41% vs. 31%), while more in the MBMI program
had undergone CABG surgery (26% vs. 15%). Intervals between the onset of the
qualifying clinical event and enrollment into the program were three months
longer in the Ornish program than the MBMI program (270 days vs. 169 days,
p50.02) due in part to the fact that enrollment was by cohort into the Ornish
Effects of Lifestyle Modification Programs
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program and continuous into the MBMI program. Large majorities of
participants were receiving antilipemics (87%) and/or beta-blockers (79%) at the
time of enrollment.
Baseline levels of cardiac risk factors are summarized in Table 3. The average
participant in both programs combined was moderately overweight with a mean
body mass index (BMI) of 28.8 kg/m2, had normal total cholesterol (161 mg/dl)
and LDL cholesterol (89 mg/dl), had mean SBP of 133 mmHg, and mean DBP of
73 mmHg. These baseline risk factor levels reflect, in part, the high proportions of
participants who were receiving antilipemics, beta-blockers, and/or antihyper-











Enrollment 0 100% 100% 100%
3 1–6 98% 98% 98%
12 7–18 67% 72% 71%
24 19–30 47% 58% 56%
MBMI denotes the Cardiac Wellness Program of the Benson-Henry Mind Body Institute. Ornish denotes The Dean Ornish Program for Reversing Heart
Disease. The observation closest to the target time was taken, provided it was within the stated interval.
doi:10.1371/journal.pone.0114772.t001










Age (mean years) 71.5 71.2 71.6 N
Gender (% male) 65% 66% 65% N
Race (% white) 85% 86% 85% N
Education
Less than HS 8% 5% 10% N
HS graduate or GED 33% 37% 32% N
Some college 22% 20% 22% N
4-year college degree 15% 17% 14% N
Some post-graduate credits 23% 21% 23% N
Type of Qualifying Event
AMI, no cardiac procedure 28% 25% 29% N
Angina only 15% 19% 14% N
CABG 23% 15% 26% 0.008
PCI only 33% 41% 31% 0.032
Medications at Baseline
Antilipemics (%) 87% 81% 88% 0.017
Beta-blockers (%) 79% 79% 80% N
MBMI is the Benson-Henry Mind/Body Medical Institute. Ornish is The Dean Ornish Program for Reversing Heart Disease. AMI is acute myocardial
infarction; CABG is coronary artery bypass graft surgery; PCI is percutaneous coronary intervention. Levels of statistical significance between programs are
based on 262 chi-squares for each level of categorical variables and t-tests for continuous variables. N is not significant.
doi:10.1371/journal.pone.0114772.t002
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tensive agents when they entered the demonstration. The mean baseline systolic
blood pressure was higher in MBMI than Ornish program participants
(134.6 mmHg vs. 128.8 mmHg; p50.002), and baseline cardiac functional
capacity was lower in MBMI program participants (6.9 METs vs. 8.2 METs;
p,0.001).
Selected results from the baseline survey are shown in Table 4. The overall
response rate was 79%. Participants in the Ornish program were more self-
confident of their ability to lose weight and to keep it off than were those in the
MBMI program (p,0.001). Most participants indicated they were receiving very
good or excellent support from friends or family, and more than half had smoked
over 100 cigarettes at some time during their lifetimes. No patient was smoking at
the time of enrollment, since both programs required smoking cessation as a
condition for program eligibility.
Changes in Cardiac Risk Factor Levels
Mean changes in cardiac risk factor levels during the lifestyle programs are shown
in Table 5. By the end of the intense 3-month intervention, statistically significant
improvements had occurred in most risk factors in both Ornish and MBMI
program participants. The exception is HDL cholesterol, which decreased in
Ornish program participants. Cardiac functional capacity improved significantly
in participants in both programs. Supplemental analysis found that changes in
total cholesterol and LDL cholesterol were of similar magnitudes whether or not
participants were receiving antilipemics at baseline (data not shown). The
magnitudes of change in risk factors at each time point were almost always greater
in participants who remained active in the program (FULL). However, the





Risk Factor Mean SD Mean SD Mean p-value
Body weight (lbs.) 184.0 36.1 183.4 34.2 0.6 0.864
BMI (kg/m3) 28.8 4.4 28.9 4.7 20.1 0.870
SBP (mmHg) 128.8 17.1 134.6 19.0 25.7 0.002
DBP (mmHg) 72.4 10.1 73.0 10.5 20.5 0.613
Total cholesterol (mg/dl) 163.7 47.5 160.3 36.2 3.4 0.367
LDL (mg/dl) 89.6 39.3 89.2 29.4 0.4 0.905
HDL (mg/dl) 44.9 12.8 43.6 12.2 1.2 0.312
Triglycerides (mg/dl) 145.5 77.3 139.9 75.4 5.7 0.044
Cardiac functional capacity (METs) 8.2 2.1 6.9 2.0 1.3 0.000
SD is standard deviation; BMI is body mass index; SBP is systolic blood pressure; DBP is diastolic blood pressure; mmHg is millimeters of mercury; mg/dl is
milligrams per deciliter; HDL is high density lipoprotein; LDL is low density lipoprotein; cardiac functional capacity is rated on a 15-point scale; higher scores
indicate better cardiac function. MBMI is the Benson-Henry Mind/Body Medical Institute. Ornish is The Dean Ornish Program for Reversing Heart Disease.
doi:10.1371/journal.pone.0114772.t003
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directions of changes, levels of statistical significance, and time patterns were
similar in the ANY and FULL groups.
In both programs, the magnitudes of changes were generally greatest at the end
of the 12-month active intervention phase, but favorable changes were maintained
at 24 months in participants who continued in the lifestyle program. Both
programs achieved significant weight loss, but the magnitude of changes was
greater in the Ornish program. Reductions in DBP and SBP were greater in the





Topic of Question N Ornish MBMI
I would achieve a 15 lb. weight loss in 3 months
if I tried to.(15very likely; 55very unlikely)
329 2.1 2.8 0.001
If successful, I would keep weight off for 1 year (15very
likely; 55very unlikely)
332 1.9 2.3 0.001
Success in facing life’s challenges (3 questions on 4
point scales and summed; 0-not at all true; 125exactly true)
461 6.9 6.8 0.53
Overall support from family and friends (15poor;
55excellent)
459 4.4 4.4 0.59
My overall health is (15poor; 55excellent) 454 3.4 3.2 0.18
Ever smoked 100 cigarettes (% yes) 459 54.4% 57.4% 0.59
MBMI is the Benson-Henry Mind/Body Medical Institute. Ornish is The Dean Ornish Program for Reversing Heart Disease.
doi:10.1371/journal.pone.0114772.t004
Table 5. Average Changes in Cardiac Risk Factor Levels from Baseline Values by Program and Time Point.






























BMI (kg/m3) 21.3{ 21.6{ 21.8{ 22.1{ 21.3{ 20.6{ 20.7{ 21.0{ 20.9{ 20.5{
SBP (mmHg) 24.0{ 26.3{ 24.8* 27.5{ 24.0N 23.1{ 24.0{ 25.6{ 26.4{ 26.9{
DBP (mmHg) 22.2N 23.4{ 23.4{ 24.5{ 21.2N 23.1{ 23.9{ 24.3{ 24.9{ 23.5{
Total cholesterol
(mg/dl)
219.1{ 223.8{ 29.4* 211.4* 212.6* 28.9{ 29.6{ 28.4{ 29.1{ 28.2{
LDL (mg/dl) 210.9{ 214.9{ 24.9 N 26.0N 210.5* 27.4{ 27.6{ 27.5{ 27.9{ 29.1{
HDL (mg/dl) 25.1{ 25.8{ 21.1 N 21.6N 1.6N 0.8* 1.0* 2.9{ 3.2{ 2.7{
Triglycerides (mg/
dl)
211.5N 214.3N 214.9* 215.1N 213.0N 210.0{ 210.5{ 217.0{ 217.3{ 28.4*
Cardiac Functional
Capacity (METs)
1.2{ 1.4{ 1.5{ 1.6{ 1.1{ 1.5{ 1.6{ 2.0{ 2.0{ 1.6{
Statistical significance: N denotes not significant, *p,0.05, {p,0.01, {p,0.001.
MBMI is the Benson-Henry Mind/Body Medical Institute. Ornish is The Dean Ornish Program for Reversing Heart Disease. BMI is body mass index; SBP is
systolic blood pressure; DBP is diastolic blood pressure; mmHg is millimeters mercury; HDL is high density lipoprotein; LDL is low density lipoprotein; METs
are metabolic equivalents; mos. denotes months of follow-up; ANY denotes all participants at the follow-up time; FULL denotes participants with final (24
month) data; n denotes the number of participants in that column. Data are not shown for 24 mos. ANY, but the patients and results are very similar to those
for 24 mos. FULL.
doi:10.1371/journal.pone.0114772.t005
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MBMI program. Sustained reductions in LDL occurred in both programs. The
levels of HDL cholesterol increased steadily in MBMI participants, while the initial
decrease in HDL in Ornish program participants returned to baseline levels.
The benefits of the programs are presented in terms of the attainment of
therapeutic targets as defined by the American Heart Association in Fig. 1. These
are the BMI of 25 or below, SBP of 140 mmHg or below, LDL of 100 mg/dl or
less, and HDL above 40 mg/dl in men and 50 mg/dl in women. The proportions
of participants with normal weights (BMI) increased from 19% at baseline to 40%
after 2 years in the Ornish program and from 20% to 28% in the MBMI program.
In both programs, more than 80% of goal weight achievement occurred during
the first year, though some further progress was made in the second year for
patients who remained active in the program. Maximum improvements in SBP
control were achieved at the end of the active intervention year, with an increase
from 61% to 78% in the MBMI program and from 68% to 80% in the Ornish
program reaching SBP target levels. For LDL, 71% of each program’s participants
were at goal levels at baseline. This proportion increased in the MBMI program to
82%, while changes in the Ornish program participants were less consistent.
Increases in HDL occurred in the MBMI program, with results at two years being
significantly higher than at baseline. In Ornish, HDL levels decreased during the
first 3-months and then returned gradually to baseline levels.
It is likely that FULL participants (those with full data) were more motivated
than those who missed one or more time points. Of the 32 possible comparisons
(8 indicators62 programs62 time periods), 31 (97%) showed larger magnitude
of changes for FULL participants compared to ANY at 3 and 12 months of follow
up. This comparison suggests, as expected, that higher motivation was associated
with greater change. On the other hand, even the participants who did not
complete 24 month follow up achieved significant improvements at earlier time
periods. Taking 3-month LDL changes as an example, the 62 Ornish and 115
MBMI dropouts after 3 months (i.e. those in ANY but not FULL) showed
statistically significant reductions of 6.9 mg/dl (p,.05) and 7.0 mg/dl (p,.01),
respectively.
Comparison of changes between the 12-month FULL and 24-month FULL
participants shows the persistence of risk factor changes. Of the 16 possible
comparisons (8 indicators times 2 groups), 13 show attenuation (though 9 still
remain significantly better than baseline), while 3 show strengthening. Strikingly,
LDL improvements were greater at 24 months than at 12 months for both
programs. The lifestyle programs apparently contributed to careful attention to
antilipemic medications and regular physical activity that are important for this
risk factor.
Risk Factor Changes Controlling for Participant and Program
Characteristics
Multivariable regressions examine changes in cardiac risk factors adjusting for
baseline patient-level characteristics including age, gender, race, type of qualifying
Effects of Lifestyle Modification Programs
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clinical event, risk factor levels, program (Ornish or MBMI), and time period
(Table 6). Decreases in risk factors were strongly associated with higher baseline
values. These relationships may reflect greater incentives in participants with
higher baseline values and/or regression to the mean. Participation in the Ornish
program was associated with significantly greater reductions in BMI and SBP
(controlling for a lower mean baseline SBP), favorable changes in LDL, and
unfavorable changes (reductions) in HDL early during participation that waned
over time. In patients who had received CABG surgery, BMI, SBP, DBP, and
cardiac functional capacity each increased over the two-year period compared
with participants who entered the lifestyle modification program with stable
angina. These results probably reflect persistent motivation in patients who
undergo cardiac revascularization. Participants who had had AMIs but did not
Fig. 1. Proportions of Participants in Each Lifestyle Modification Program at Targeted Risk Factor
Levels at Each Time Point. Notes: Targets defined as body mass index (BMI) ,525; systolic blood pressure
(SBP) ,140 mm Hg; low density lipoprotein (LDL) ,100 mg/dl; high density lipoprotein (HDL).40 mg/dl
(male) or.50 mg/dl (female). Mon denotes months. Statistical significance: * p,0.05, ** p,0.01, *** p,0.001,
N denotes not significant. McNemar’s chi-square test was used for hypothesis testing. MBMI denotes the
Cardiac Wellness Program of the Benson-Henry Mind Body Institute, Ornish is The Dean Ornish Program for
Reversing Heart Disease.
doi:10.1371/journal.pone.0114772.g001
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have subsequent revascularization procedures gained weight during the lifestyle
programs and increased their cardiac functional capacities. Women experienced
greater increases in their HDL levels, lesser decreases in LDL levels, and less
improvement in cardiac functional capacity than men, controlling for other
factors. Significant improvements in BMI, DBP, and HDL persisted over the
period of the demonstration, while those in LDL did not.
Fig. 2 summarizes findings for risk factor changes in curvilinear relationships
between risk factor changes and time. There was a gradual waning of favorable
effects after one year for changes in BMI, LDL, DBP, and cardiac functional
capacity in both programs, but sustained favorable effects for SBP and HDL levels.
Clinical Events during the Intervention Period
Adverse clinical events during the active intervention period were reported by the
clinical sites and evaluated by the Delmarva Foundation, an independent quality
monitor. An adverse event was defined as one that resulted in a prolonged lapse in
program participation and included any hospitalization, AMI, cardiac surgery or
other revascularization procedure, cardiac catheterization or coronary angiogra-
phy, emergency room visits, and death. [15] Overall, 24% of participants in the
Ornish program and 16% in the MBMI program reported one or more adverse
events. Death occurred in five participants (3.5%) in the Ornish program and

















Intercept 0.97 77.6 { 56.7 { 45.3 { 12.4 { 6.6 {
Baseline 20.07 { 20.6 { 20.7 { 20.5 { 20.3 { 20.3 {
Ornish programb 20.61 { 23 { 0.9 0.3 23.7 { 0.1
Quarterc 20.26 { 20.8 20.8 * 1.6 * 1.4 { 0.3 {
Quarter squared 0.03 { 0.1 0.1 * 20.2 * 20.1 { 20.03 {
Age (years) 0.004 0.04 0.2 * 20.1 20.01 20.05 {
Female 0.15 0.5 21.2 6.8 { 2.1 { 20.6 {
Non2white 0.07 20.3 20.01 22.7 0.7 20.2
PCId 0.19 0.9 1.1 21.6 20.95 0.3
CABGd 0.67 { 3.8 * 2.8 { 22.1 20.3 0.8 {
AMId 0.43 { 2.3 1.8 22.7 0.3 0.7 {
aStatistical significance (Sig.): *p,0.05, {p,0.01, {p,0.001.
bReference group is the (MBMI) program.
cQuarter denotes quarter year (3-month period).
dReference group is stable angina.
MBMI is the Benson-Henry Mind/Body Medical Institute. Ornish is The Dean Ornish Program for Reversing Heart Disease. BMI denotes body mass index;
HDL denotes high density lipoprotein; LDL denotes low density lipoprotein; METS denotes metabolic equivalents; PCI is percutaneous coronary
intervention; CABG is coronary artery bypass graft surgery; AMI is acute myocardial infarction.
doi:10.1371/journal.pone.0114772.t006
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three participants (0.7%) in the MBMI program (p50.026). The independent
quality monitor thoroughly examined all deaths and concluded that none was
related to participation in the lifestyle modification program.
Fig. 2. Risk Factor Changes in the Two Lifestyle Modification Programs Based on Multivariable Regressions with Quadratic Terms for Time. Notes:
MBMI denotes the Cardiac Wellness Program of the Benson-Henry Mind Body Institute; Ornish is The Dean Ornish Program for Reversing Heart Disease.
BMI denotes body mass index; LDL denotes low density lipoprotein; HDL denotes high density lipoprotein; SBP denotes systolic blood pressure; DBP
denotes diastolic blood pressure.
doi:10.1371/journal.pone.0114772.g002
Effects of Lifestyle Modification Programs
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Discussion
Enrollment into Medicare’s Lifestyle Modification Demonstration was lower than
anticipated by CMS despite an extension of the enrollment period to six years.
Only 580 of the targeted 3,600 Medicare beneficiaries were enrolled. Reasons
stemmed from stringent eligibility requirements, rigorous clinical and data
protocols, the time demands of the programs on participants, and required
participant copayments in some clinical centers. Enrollment was greater in the
MBMI program than the Ornish program (440 vs. 140), possibly due to the
Ornish program’s greater time demands, focus on adopting very low fat
vegetarian diets, and enrollment by cohort at three or four month intervals rather
than continuously. The adherence of enrollees to program requirements was
excellent, with 98% completing the intense initial three-month period and 71%
completing the year-long active program. Participants were highly motivated and
may not be typical of all patients with coronary heart disease.
More than half of participants (56%) had had a recent coronary revascular-
ization procedure as their qualifying events, while the remainder had either a
recent AMI without revascularization or stable angina pectoris. This clinical
spectrum is similar to findings in a study of Medicare beneficiaries who received
traditional cardiac rehabilitation funded by Medicare. [16] All participants were
under the active care of physicians at baseline, and nearly 90% were receiving
antilipemic agents and 80% beta-blockers at the time of enrollment into the
demonstration. Group means for total and LDL cholesterols were within normal
ranges at the time of enrollment at 161 mg/dl and 89 mg/dl, respectively.
Statistically significant reductions were achieved by both programs in body
weight, SBP, DBP, and LDL cholesterol, and were well-sustained in participants
who remained in the program for two years. Changes in BMI were greater in
Ornish program participants. With the Ornish program being more stringent and
having lower enrollment, it may have attracted more highly motivated
participants. While more highly motivated participants showed greater changes,
even those with less motivation achieved significant improvements at 3 months. A
transient reduction in HDL levels in Ornish program participants at the end of the
three-month intensive intervention period returned to baseline levels after 12
months. This finding has been observed previously in individuals receiving a
vegetarian diet. [17] Though lower levels of HDL are associated with a higher risk
of coronary artery disease in epidemiologic studies, even after controlling for LDL
levels, [18] the implications of these transient HDL changes are not known. The
MBMI program achieved statistically significant increases in HDL levels at each
time point.
Based on the number and description of adverse events, participation was felt to
be safe. The rate of adverse cardiac events was consistent with the literature. For
example, a review of PCI studies reported 868 adverse cardiac events in 6,922
patients over one year, a rate of 12.5% [19].
As no control group was available for this study, we searched the literature for
relevant comparisons. We located a Canadian study with 126 participants in
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traditional CR [20] and a European trial with 68 patients with medical
management but no CR or lifestyle program. [21] The data in both studies
permitted calculation of risk factor changes from baseline to 3 months on subjects
providing virtually all requested data, comparable to the FULL analyses in this
study. In the study of traditional CR, three risk factors (SBP, DBP, and HDL) all
showed significant improvements that exceeded those of the Ornish and MBMI
programs. On the other hand, for the other three comparably measured risk
factors (total cholesterol, LDL, and BMI), the gains were greater and statistically
significant only in the Ornish and MBMI [20].
In the no lifestyle study, three risk factors (SBP, SBP, and BMI) showed
significant improvements (declines) since baseline, one risk factor (HDL) showed
a significant deterioration (increase) over baseline, while two risk factors (total
cholesterol and LDL) showed no significant change. [21] Surprisingly, the pure
controls achieved greater 3-month improvements in SBP and DBP than the
lifestyle programs. This is probably because the pure controls had elevated average
baseline blood pressures (SBP 150/DBP 92), whereas those of Ornish (129/72) and
MBMI (135/73) participants were normal. Overall, the Ornish and MBMI
programs generally achieved generally superior short-term results over these pure
controls, with at least one of the lifestyle programs registering significant
improvements on all indicators. These comparisons suggest that while lifestyle
programs are better than no-lifestyle controls, the advantage of lifestyle programs
over traditional CR may not lie in superior short-term results, but in documented
sustained improvements through 24 months of follow up.
The clinical processes that lead to atherosclerosis may begin early in life and
lead to cardiac events earlier or later in life. Effective primary or primordial
prevention, including pharmacological treatment of risk factors in individuals
with no overt evidence of cardiovascular disease, has been shown to reduce the
frequency of later cardiac events and may be cost-effective or even cost-saving.
[22] Primary prevention of cardiovascular disease has been strongly recom-
mended by the Preventive Services Task Force based on a recent review of 74
clinical trials, [23, 24] which provided convincing evidence that improvements in
total cholesterol, low-density lipoproteins, systolic and diastolic blood pressures,
fasting glucose, diabetes incidence, and body weight can result from lifestyle
counseling and treatment with medications in asymptomatic individuals with
elevated risk factors. These findings underscore the importance of primary
prevention and the risk factor benefits reported here in patients with symptomatic
cardiovascular disease.
Strengths and limitations of our study need to be acknowledged. Major
strengths lie in the systematic and complete data collected by the Delmarva
Foundation on changes in cardiac risk factors and clinical events during the
demonstration. Limitations relate principally to its observational pre-post design
and the absence of a control group. Regression to the mean may play a role in
explaining some of the observed favorable changes in cardiac risk factors. Also,
findings in the highly motivated individuals who enrolled in the programs may
not apply to less-strongly motivated individuals with CHD. Direct comparisons of
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outcomes with patients who received traditional cardiac rehabilitation or no
rehabilitation will be required to determine the relative effectiveness and cost-
effectiveness of these two types of programs.
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